Zhang Z, Wei M, Jia B, Yuan Y
Microorganisms. 2025; 13(1).
PMID: 39858819
PMC: 11767524.
DOI: 10.3390/microorganisms13010051.
Gangar T, Patra S
3 Biotech. 2023; 13(12):401.
PMID: 37982084
PMC: 10654327.
DOI: 10.1007/s13205-023-03806-6.
Darby E, Trampari E, Siasat P, Gaya M, Alav I, Webber M
Nat Rev Microbiol. 2022; 21(5):280-295.
PMID: 36411397
DOI: 10.1038/s41579-022-00820-y.
Takemoto J, Altenberg G, Poudyal N, Subedi Y, Chang C
Front Microbiol. 2022; 13:1000199.
PMID: 36212866
PMC: 9537547.
DOI: 10.3389/fmicb.2022.1000199.
Dezanet C, Kempf J, Mingeot-Leclercq M, Decout J
Int J Mol Sci. 2020; 21(19).
PMID: 33049963
PMC: 7583001.
DOI: 10.3390/ijms21197411.
Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.
Chandrika N, Garneau-Tsodikova S
Chem Soc Rev. 2018; 47(4):1189-1249.
PMID: 29296992
PMC: 5818290.
DOI: 10.1039/c7cs00407a.
A structural basis for the antibiotic resistance conferred by an N1-methylation of A1408 in 16S rRNA.
Kanazawa H, Baba F, Koganei M, Kondo J
Nucleic Acids Res. 2017; 45(21):12529-12535.
PMID: 29036479
PMC: 5716097.
DOI: 10.1093/nar/gkx882.
A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.
Chandrika N, Garneau-Tsodikova S
Medchemcomm. 2016; 7(1):50-68.
PMID: 27019689
PMC: 4806794.
DOI: 10.1039/C5MD00453E.
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
Fosso M, Shrestha S, Green K, Garneau-Tsodikova S
J Med Chem. 2015; 58(23):9124-32.
PMID: 26592740
PMC: 5154386.
DOI: 10.1021/acs.jmedchem.5b01375.
Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics.
Shalev M, Rozenberg H, Smolkin B, Nasereddin A, Kopelyanskiy D, Belakhov V
Nucleic Acids Res. 2015; 43(17):8601-13.
PMID: 26264664
PMC: 4787808.
DOI: 10.1093/nar/gkv821.
Antifungal Amphiphilic Aminoglycosides.
Chang C, Takemoto J
Medchemcomm. 2014; 5(8):1048-1057.
PMID: 25110571
PMC: 4125127.
DOI: 10.1039/C4MD00078A.
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.
Labby K, Garneau-Tsodikova S
Future Med Chem. 2013; 5(11):1285-309.
PMID: 23859208
PMC: 3819198.
DOI: 10.4155/fmc.13.80.
Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance.
Shi K, Caldwell S, Fong D, Berghuis A
Front Cell Infect Microbiol. 2013; 3:22.
PMID: 23805415
PMC: 3691515.
DOI: 10.3389/fcimb.2013.00022.
A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.
Das I, Desire J, Manvar D, Baussanne I, Pandey V, Decout J
J Med Chem. 2012; 55(13):6021-32.
PMID: 22698070
PMC: 3400927.
DOI: 10.1021/jm300253q.
Selectively guanidinylated aminoglycosides as antibiotics.
Fair R, Hensler M, Thienphrapa W, Dam Q, Nizet V, Tor Y
ChemMedChem. 2012; 7(7):1237-44.
PMID: 22639134
PMC: 3383777.
DOI: 10.1002/cmdc.201200150.
6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes.
Herzog I, Green K, Berkov-Zrihen Y, Feldman M, Vidavski R, Eldar-Boock A
Angew Chem Int Ed Engl. 2012; 51(23):5652-6.
PMID: 22499286
PMC: 3390782.
DOI: 10.1002/anie.201200761.